Montreux Equity Partners

Montreux Equity Partners is a private investment firm dedicated to building leading healthcare companies of tomorrow. Founded in 1993, the firm focuses on making growth capital investments in commercial-stage companies with highly differentiated products, technologies, and services. At the time of investment, these companies typically have revenues between $5 million and $50 million. Montreux's capital supports product expansion, new market entry, and strategic acquisitions.

The firm's investment strategy centers on sectors addressing compelling domestic and global health trends, particularly in healthcare and technology. Montreux is currently investing out of its fifth fund, continuing its commitment to fostering innovation and growth in the healthcare industry. The firm has a history of successful investments, including notable exits such as TigerConnect, Pulmonx, and Colorescience.

Montreux Equity Partners is headquartered in San Francisco, California, and operates with a team of professionals bringing over 70 years of combined experience in operating and investing in life sciences-focused companies. The firm's approach emphasizes collaboration with entrepreneurs and management teams to build leading healthcare companies of tomorrow.